Sulfadoxine Pyrimethamine and Dihydroartemisinin

Name: Sulfadoxine Pyrimethamine and Dihydroartemisinin
Brand: Artemisine Medicines Technology Co., Ltd.

Tablets

Sulfadoxine Pyrimethamine and Dihydroartemisinin

Sulfadoxine Pyrimethamine and Dihydroartemisinin — GMP manufactured tablets by Artemisine Medicines Technology. Original manufacturer supply with stable quality, factory direct price and full batch documentation for global markets.

Product Name	Sulfadoxine Pyrimethamine and Dihydroartemisinin
Dosage Form	Tablets
Strength	175 mg / 60 mg
Standards	BP / ENTERPRISE
Packing	Customized per market requirement (bottle / blister / box)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Tablets

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

Severe falciparum malaria (injectable artesunate is WHO first-line, then a full ACT course) and uncomplicated malaria as combination therapy.

💧Administration▾

Artesunate: intravenous or intramuscular injection, reconstituted immediately before use. Oral artemether/artesunate always combined with a partner antimalarial.

⚖️Dosage▾

Artesunate injection adults and children 2.4 mg/kg (max 120 mg) at 0, 12 and 24 h, then once daily until oral therapy can be taken, followed by a full ACT course. Oral artesunate 4 mg/kg once daily for 3 days with a partner drug.

⚠️Precautions & Warnings▾

Hospital use; risk of delayed haemolysis after treatment (monitor haemoglobin for 4 weeks). Avoid in first-trimester pregnancy unless severe malaria when benefit outweighs risk.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Sulfadoxine Pyrimethamine and Dihydroartemisinin — Frequently Asked Questions

Which documents are provided for Sulfadoxine Pyrimethamine and Dihydroartemisinin registration?

Every batch of Sulfadoxine Pyrimethamine and Dihydroartemisinin ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Sulfadoxine Pyrimethamine and Dihydroartemisinin?

MOQ and lead time for Sulfadoxine Pyrimethamine and Dihydroartemisinin depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Sulfadoxine Pyrimethamine and Dihydroartemisinin, subject to the regulatory requirements of the destination market.

Which markets have you exported tablets products to?

We have supplied tablets products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Sulfadoxine Pyrimethamine and Dihydroartemisinin controlled?

Sulfadoxine Pyrimethamine and Dihydroartemisinin is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›